Latest news for Oxide (OTC:OXIDF) Stock

Oxide Corp is engaged in the development, manufacture, and sales of oxide single crystals, optical components, laser light sources, and measurement systems in the field of optics.

Oxide Corp

Truist Securities analyst Michael Lewis maintains BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>) with a Hold and raises the price target from $77 to $83.

News

Price Target

Analyst Ratings

Truist Securities Maintains Hold on BXP, Raises Price Target to $83

Contracts

TotalEnergies Announced The Signing Of An Agreement With Swiss Asset Manager Partners Group For The Acquisition Of  VSB Group for $1.57B

<a href="https://www.globenewswire.com/Tracker?data=7mIikGpwZtS2FyzxskYQEBFouIPsHrZMTk2xB1K9xcN9JE4fcLFl9KSnXfk8xI3BWMwIU_4abEO9SFq9WrU_fw==">Telesat</a>&nbsp;(TSX:<a class="ticker" href="https://www.benzinga.com/stock/TSAT#TSX">TSAT</a>), one of the world's largest and most innovative satellite operators, and MDA Space (TSX:<a class="ticker" href="https://www.benzinga.com/stock/MDA#TSX">MDA</a>), a trusted mission partner to the rapidly expanding global space industry, today announced that they have concluded a key phase in the <a href="https://www.globenewswire.com/Tracker?data=7mIikGpwZtS2FyzxskYQENXo0-VpJXmNKbby55CuvjKg2z_8ssJeGODd4gFXvLLnfza-OlyDYB2zPUdwa6GLVn2m54M94M118HVCyDceJzRKk5jpq62ua5ob0voGgZMi">Telesat Lightspeed</a> low Earth orbit (LEO) constellation program with the successful completion of the spacecraft Preliminary Design Review (PDR).
The PDR is a critical checkpoint in the program. Its successful completion demonstrates maturity in the design that meets the program's functional and performance requirements. As part of the process, the PDRs for multiple key subsystems have also been successfully completed.
The Telesat Lightspeed LEO satellite constellation is an innovative, advanced global network that will bring enterprise-class connectivity to customers worldwide. Telesat selected MDA Space as the prime satellite contractor for the constellation in 2023, awarding an initial order for 198 satellites powered by MDA AURORATM technology, the company's new digital satellite product line.
With PDRs completed, Telesat and MDA Space are now transitioning to the program's detailed engineering and manufacturing phase, including the Critical Design Review.

TSAT

TSX:MDA

TSX:TSAT

Telesat and MDA Space Has Concluded A Key Phase In The Telesat Lightspeed Low Earth Orbit Constellation Program With The Successful Completion Of The Spacecraft Preliminary Design Review

WIIM

SLND

Southland Holdings shares are trading higher after the company announced its subsidiary has been awarded a $60 million contract to construct a new wastewater treatment plant in the southwest.

Truist Securities analyst Naved Khan maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Hold and lowers the price target from $124 to $123.

ABNB

Truist Securities Maintains Hold on Airbnb, Lowers Price Target to $123

SSYS

Stratasys Named Official 3D Printing Partner Of NASCAR In Multi-Year Deal To Provide Exclusive Solutions For Parts, Tools, And Design Acceleration; Financial Terms Not Disclosed

future customers
Ra'anana, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSN#NASDAQ">RVSN</a>) (the "Company"), a technology company at the forefront of revolutionizing railway safety and the data-related market, today announces its new Software as a Service (SaaS) platform called D.A.S.H. — an innovative approach to rail safety and operational efficiency. D.A.S.H., which stands for Discover, Analyze, Secure, and Harness, encapsulates Rail Vision's mission to empower operators with actionable insights and reports.
The D.A.S.H. platform integrates seamlessly with Rail Vision's AI-driven MainLine and ShuntingYard systems, to address critical rail industry challenges. By leveraging advanced detection capabilities, big data analysis and robust safety measures, the platform enables rail operators to enhance decision-making and streamline operations. The D.A.S.H. can be integrated with existing and future big data platforms from other sensors and create a synergy.

RVSN

Rail Vision Introduces Its New Software As A Service Platform Called D.A.S.H., An Innovative Approach To Rail Safety And Operational Efficiency

Focused on advancing cloud solutions and service delivery capabilities, the new agreement refines pathways for Ingram Micro's channel partners to drive accelerated growth with AWS
Ingram Micro Inc. (NYSE:<a href="https://www.benzinga.com/stock/INGM#NYSE">INGM</a>) today announced a multi-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS) designed to drive more business to and through the global IT channel via Ingram Micro's digital twin Xvantage&#x2122;. Expanding on its successful global relationship with AWS and <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fingrammicro.gcs-web.com%2Fnews-releases%2Fnews-release-details%2Fingram-micro-announces-seamless-integration-hyperscaler&amp;esheet=54161502&amp;newsitemid=20241204778001&amp;lan=en-US&amp;anchor=new+integration+whereby+partners+can+now+access+AWS+Marketplace+through+Ingram+Micro+Xvantage&amp;index=1&amp;md5=8fd91f1698b728e75c277c511e6ff12f">new integration whereby partners can now access AWS Marketplace through Ingram Micro Xvantage</a>, the new SCA focuses on two key areas:

INGM

Ingram Micro Signs New Agreement With Amazon Web Services To Drive Channel Partner Services Capabilities And Scale

Susquehanna analyst Shyam Patil maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Neutral and raises the price target from $85 to $95.

OKTA

Susquehanna Maintains Neutral on Okta, Raises Price Target to $95

Guidance

Cabot Corporation Introduces 3-Year Financial Targets Amid Investor Day; Targets Adjusted EPS CAGR Of 7-10% From FY24-FY27, Adj. EBITDA Of $900M-$1B By FY27

Susquehanna analyst Christopher Rolland maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Positive and raises the price target from $110 to $125.

MRVL

Susquehanna Maintains Positive on Marvell Tech, Raises Price Target to $125

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2024/12/03/final-trades-amazon-agco-on-holding-and-las-vegas-sands.html">Halftime Report Final Trades</a>,&#8221; Joshua Brown of Ritholtz Wealth Management said he is <a href="https://www.benzinga.com/24/12/42301222/amazon-stock-moves-higher-as-aws-unveils-new-ai-advancements-what-you-need-to-know">staying long on </a>Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
Amazon Web Services made a slew of announcements at its re:Invent 2024 conference, including the general availability of Trainium2, new database capabilities, Bedrock updates and new foundation models. Here's what you need to know. Amazon's biggest conference of the year, AWS re:Invent 2024, kicked off this week with sessions set to run through Friday.
Brian Belski of BMO Capital Markets named AGCO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>), an industrial stock.
On Tuesday, Morgan Stanley analyst Angel Castillo initiated coverage on AGCO with an Equal-Weight rating and announced a price target of $101.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Jim Lebenthal of Cerity Partners picked On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>).
On Nov. 12, On Holding reported better-than-expected third-quarter sales results and raised its FY24 net sales guidance. On Holding reported quarterly earnings of 17 cents per share which missed the analyst consensus estimate of 23 cents per share. The company reported quarterly sales of $734.52 million, which beat the analyst consensus estimate of $704.58 million.
Stephanie Link of Hightower picked Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>), saying the stock has done nothing in four years, and 2025 sets up really well.
On Oct. 23, Las Vegas Sands reported quarterly earnings of 44 cents per share which missed the analyst consensus estimate of 54 cents per share. The company reported quarterly sales of $2.680 billion, which missed the analyst consensus estimate of $2.781 billion.
Price Action:
<ul>
<li>Amazon shares gained 1.3% to close at $213.44 on Tuesday.</li>
<li>AGCO shares fell by 0.9% to settle at $100.56 during Tuesday's session.</li>
<li>On Holding shares gained by 1.7% to close at $59.54 during Tuesday's session.</li>
<li>Las Vegas Sands fell by 2% to settle at $53.90 during the session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Long Ideas

Markets

Media

Trading Ideas

AGCO

AMZN

ONON

Amazon, AGCO, On Holding And A Casino Operator On CNBC's 'Final Trades'

ERNA

Eterna Therapeutics shares are trading higher. The stock may be moving on continued strength after the company announced yesterday the launch of research to evaluate ERNA-101's ability to induce and modulate antitumor immunity in ovarian and breast cancer models.

AMTM

Amentum-Led Team Secures $3B DOE Contract For West Valley Phase 1B Deactivation And Demolition Project In New York, Focused On Nuclear Facility Cleanup And Waste Disposal

Qualifying public and private K-12 Schools in the U.S. will be eligible to receive two free cartons (four single use doses) of neffy&#xAE; (epinephrine nasal spray) 2mg for use in emergency treatment of allergic reactions including anaphylaxis
Interested schools are encouraged to review applicable state laws and regulations to ensure neffy for undesignated use meets all requirements
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRY#NASDAQ">SPRY</a>), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, announced today that it will be launching the neffyinSchools Program in January 2025. The program will provide eligible public and private K-12 schools in the U.S. the opportunity to receive two cartons (four single use doses) of neffy&#xAE; (epinephrine nasal spray) 2mg for use in emergency situations at no cost to the school. neffy 2mg was recently approved for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh ≥30 kg (66 lbs.) Participating schools will be eligible to receive replacement doses when the product is used or expires.
Type 1 allergic reactions can be life-threatening, can happen in minutes, and&nbsp;can be caused by stinging and biting insects, foods, medication, exercise, or other unknown causes. Studies show that up to 18% of children with food allergies have had a reaction from accidentally eating food allergens while at school.1 In addition, 25% of severe and potentially life-threatening reactions (anaphylaxis) reported at schools happened in children with no previous diagnosis of food allergy.1&nbsp;&nbsp;

Biotech

General

SPRY

ARS Pharmaceuticals Announces That It Will Be Launching The neffyinSchools Program In January 2025; The Program Will Provide Eligible Public And Private K-12 Schools In The U.S. The Opportunity To Receive Two Cartons Of neffy 2mg For Use In Emergency Situations At No Cost To The School

AUUD

Auddia Says 30-Day User Retention Accelerated To 21% In October

TZUP

Thumzup Media Partners With AI Expert Tedras Global Solutions To Drive Innovation And Accelerate Growth Of Disruptive Social Media Ad-Tech Platform

Stifel analyst Parker Lane maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Buy and raises the price target from $390 to $425.

Stifel Maintains Buy on Salesforce, Raises Price Target to $425

ENSC

Ensysce Biosciences Initiates PARtnership With A Drug Manufacturer For The Development And Commercial Launch Of PF614 And PF614-MPAR, Including A $10M Commitment From The Drug Manufacturer

HRTX

Heron Therapeutics shares are trading higher. Needham reiterated a Buy rating on the stock.

Oxide

Comments

Oxide

News

Latest news for Oxide (OTC:OXIDF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga